Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Suppression of FOXO1a gene might kill resistant ARMS tumors

22.09.2005


FOXO1a caused death of tumor cells in laboratory study by triggering expression of caspase-3, which blocks cell division and causes cells to undergo apoptosis, according to St. Jude.



The loss of function of a gene called FOXO1a plays an important role in the development of the most common cancer of soft tissues in children, and restoring the function of that gene in cancer cells suppresses that cancer, according to investigators at St. Jude Children’s Research Hospital. The cancer, called alveolar rhabdomyosarcoma (ARMS), arises from immature skeletal muscle cells that remain partially differentiated (do not acquire all the characteristics of a mature muscle cell).

The St. Jude team found that the expression of FOXO1a is suppressed in ARMS and that the gene potently suppresses tumor activity when re-introduced into ARMS tumor cells in the laboratory. Therefore, the investigators theorize that the observed loss of FOXO1a activity is a pivotal step in the ARMS development. The FOXO1a gene produces the protein FOXO1a. Gene expression refers to the production of the protein coded for by a particular gene. A report on these findings appears in the September 12 issue of Journal of Cell Biology.


FOXO1a kills ARMS cells by activating the gene that produces a protein called caspase-3. Caspase-3 is a key player in the signaling pathway that triggers programmed cell death (apoptosis). Although caspase-3 triggers apoptosis in abnormal cells, normal myoblasts (immature muscle cells) also depend on caspase-3 activity in order to differentiate into mature muscle cells.

"Our study shows that suppression of FOXO1a is necessary for ARMS cells to survive and avoid caspase-3-mediated apoptosis, even in the more aggressive secondary tumors that are highly resistant to irradiation and chemotherapy, said Gerard Grosveld, Ph.D., chair of genetics and tumor cell biology at St. Jude. Grosveld is senior author of the paper. His team previously reported that FOXO1a (also called FKHR) is the master regulator that controls the differentiation of myoblasts into muscle cells (EMBO Journal 22:1147-1157; 2003).

The investigators also showed that the loss of FOXO1a expression works in combination with another mutation in ARMS. Specifically, muscle cells first acquire a mutation called a chromosomal translocation. Translocation occurs when two chromosomes break and exchange the pieces of DNA that break off. Because the chromosome breaks occur within genes, a piece of a gene from one chromosome is able to combine with the remaining piece of gene on the other chromosome. When two broken normal genes combine, the outcome is an abnormal gene called a fusion gene. In ARMS, the two possible fusion genes that arise by translocation are called PAX3-FOXO1a and PAX7-FOXO1a. Translocation destroys one of the two copies of FOXO1a, Grosveld noted.

If the remaining FOXO1a gene then fails to produce FOXO1a protein, the combination of the absence of FOXO1a with the gene translocation causes ARMS.

The finding suggests that drugs aimed at restoring or increasing the activity of FOXO1a in ARMS might successfully treat this cancer in children by forcing the abnormal cells to undergo apoptosis. Furthermore, the mutations that cause ARMS do not occur in the related but different muscle cancer ERMS (embryonal rhabdomyosarcoma), the researchers reported. Therefore, forcing the expression of FOXO1a in these cancer cells does not cause them to undergo apoptosis.

The proteins made by the PAX3 and PAX7 genes play critical roles in the development and differentiation of muscle cells, and the translocations disrupt their important functions, according to Grosveld. "So it’s not surprising that ARMS cells look like skeletal muscle cells that only partially differentiated," Grosveld said. "And in the absence of FOXO1a protein, these abnormal cells simply continue to grow and multiply and cause ARMS."

"Our findings emphasize that ARMS and ERMS are different forms of rhabdomyosarcoma that arise by independent mutations," said Philppe R. J. Bois, Ph.D., the postdoctoral fellow who did most of this work. "Therefore, different strategies will be required to improve treatment outcomes for each of these tumors." Bois is first author of the paper.

Other authors of this paper include Kamel Izeradjene, Peter J. Houghton, John L. Cleveland and Janet A. Houghton.

Kelly Perry | EurekAlert!
Further information:
http://www.stjude.org

More articles from Life Sciences:

nachricht Climate Impact Research in Hannover: Small Plants against Large Waves
17.08.2018 | Leibniz Universität Hannover

nachricht First transcription atlas of all wheat genes expands prospects for research and cultivation
17.08.2018 | Leibniz-Institut für Pflanzengenetik und Kulturpflanzenforschung

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>